312 related articles for article (PubMed ID: 25662516)
1. Thioredoxin-interacting protein: a potential therapeutic target for treatment of progressive fibrosis in diabetic nephropathy.
Tan CY; Weier Q; Zhang Y; Cox AJ; Kelly DJ; Langham RG
Nephron; 2015; 129(2):109-27. PubMed ID: 25662516
[TBL] [Abstract][Full Text] [Related]
2. Thioredoxin-Interacting Protein Deficiency Protects against Diabetic Nephropathy.
Shah A; Xia L; Masson EA; Gui C; Momen A; Shikatani EA; Husain M; Quaggin S; John R; Fantus IG
J Am Soc Nephrol; 2015 Dec; 26(12):2963-77. PubMed ID: 25855771
[TBL] [Abstract][Full Text] [Related]
3. Role of the thioredoxin interacting protein in diabetic nephropathy and the mechanism of regulating NOD‑like receptor protein 3 inflammatory corpuscle.
Gu C; Liu S; Wang H; Dou H
Int J Mol Med; 2019 Jun; 43(6):2440-2450. PubMed ID: 31017263
[TBL] [Abstract][Full Text] [Related]
4. NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice.
Wu M; Han W; Song S; Du Y; Liu C; Chen N; Wu H; Shi Y; Duan H
Mol Cell Endocrinol; 2018 Dec; 478():115-125. PubMed ID: 30098377
[TBL] [Abstract][Full Text] [Related]
5. Salidroside alleviates high glucose-induced oxidative stress and extracellular matrix accumulation in rat glomerular mesangial cells by the TXNIP-NLRP3 inflammasome pathway.
Wang S; Zhao X; Yang S; Chen B; Shi J
Chem Biol Interact; 2017 Dec; 278():48-53. PubMed ID: 29031534
[TBL] [Abstract][Full Text] [Related]
6. Thioredoxin interacting protein (TXNIP) regulates tubular autophagy and mitophagy in diabetic nephropathy through the mTOR signaling pathway.
Huang C; Zhang Y; Kelly DJ; Tan CY; Gill A; Cheng D; Braet F; Park JS; Sue CM; Pollock CA; Chen XM
Sci Rep; 2016 Jul; 6():29196. PubMed ID: 27381856
[TBL] [Abstract][Full Text] [Related]
7. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
[TBL] [Abstract][Full Text] [Related]
8. A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy.
Hamada Y; Fukagawa M
Kobe J Med Sci; 2007; 53(1-2):53-61. PubMed ID: 17582205
[TBL] [Abstract][Full Text] [Related]
9. Tranilast attenuates the up-regulation of thioredoxin-interacting protein and oxidative stress in an experimental model of diabetic nephropathy.
Tan SM; Zhang Y; Cox AJ; Kelly DJ; Qi W
Nephrol Dial Transplant; 2011 Jan; 26(1):100-10. PubMed ID: 20573806
[TBL] [Abstract][Full Text] [Related]
10. Endoplasmic reticulum stress related factor IRE1α regulates TXNIP/NLRP3-mediated pyroptosis in diabetic nephropathy.
Ke R; Wang Y; Hong S; Xiao L
Exp Cell Res; 2020 Nov; 396(2):112293. PubMed ID: 32950473
[TBL] [Abstract][Full Text] [Related]
11. Camel milk attenuates the biochemical and morphological features of diabetic nephropathy: inhibition of Smad1 and collagen type IV synthesis.
Korish AA; Abdel Gader AG; Korashy HM; Al-Drees AM; Alhaider AA; Arafah MM
Chem Biol Interact; 2015 Mar; 229():100-8. PubMed ID: 25617480
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation.
Wang S; Li Y; Fan J; Zhang X; Luan J; Bian Q; Ding T; Wang Y; Wang Z; Song P; Cui D; Mei X; Ju D
Cell Death Dis; 2017 Jul; 8(7):e2937. PubMed ID: 28726774
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria-targeted peptide SS-31 attenuates renal injury via an antioxidant effect in diabetic nephropathy.
Hou Y; Li S; Wu M; Wei J; Ren Y; Du C; Wu H; Han C; Duan H; Shi Y
Am J Physiol Renal Physiol; 2016 Mar; 310(6):F547-59. PubMed ID: 26719366
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of ginsenoside Rg5 against kidney injury via inhibition of NLRP3 inflammasome activation and the MAPK signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
Zhu Y; Zhu C; Yang H; Deng J; Fan D
Pharmacol Res; 2020 May; 155():104746. PubMed ID: 32156650
[TBL] [Abstract][Full Text] [Related]
15. Timosaponin B-II ameliorates diabetic nephropathy via TXNIP, mTOR, and NF-κB signaling pathways in alloxan-induced mice.
Yuan YL; Guo CR; Cui LL; Ruan SX; Zhang CF; Ji D; Yang ZL; Li F
Drug Des Devel Ther; 2015; 9():6247-58. PubMed ID: 26664046
[TBL] [Abstract][Full Text] [Related]
16. Cepharanthine and Piperine ameliorate diabetic nephropathy in rats: role of NF-κB and NLRP3 inflammasome.
Samra YA; Said HS; Elsherbiny NM; Liou GI; El-Shishtawy MM; Eissa LA
Life Sci; 2016 Jul; 157():187-199. PubMed ID: 27266851
[TBL] [Abstract][Full Text] [Related]
17. Norcantharidin attenuates tubulointerstitial fibrosis in rat models with diabetic nephropathy.
Li Y; Chen Q; Liu FY; Peng YM; Hou T; Duan SB; Li J; Luo JH; Sun L; Ling GH
Ren Fail; 2011; 33(2):233-41. PubMed ID: 21332346
[TBL] [Abstract][Full Text] [Related]
18. Effects and clinical significance of pentoxifylline on the oxidative stress of rats with diabetic nephropathy.
An ZM; Dong XG; Guo Y; Zhou JL; Qin T
J Huazhong Univ Sci Technolog Med Sci; 2015 Jun; 35(3):356-361. PubMed ID: 26072073
[TBL] [Abstract][Full Text] [Related]
19. Apocynin inhibited NLRP3/XIAP signalling to alleviate renal fibrotic injury in rat diabetic nephropathy.
Xin R; Sun X; Wang Z; Yuan W; Jiang W; Wang L; Xiang Y; Zhang H; Li X; Hou Y; Sun W; Du P
Biomed Pharmacother; 2018 Oct; 106():1325-1331. PubMed ID: 30119203
[TBL] [Abstract][Full Text] [Related]
20. Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome.
Ding T; Wang S; Zhang X; Zai W; Fan J; Chen W; Bian Q; Luan J; Shen Y; Zhang Y; Ju D; Mei X
Phytomedicine; 2018 Mar; 41():45-53. PubMed ID: 29519318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
